Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice

We have recently developed probiotics that can express bovine, human, or porcine lactoferrin (LF), and the present study evaluated the effect of these probiotics in improving non-alcoholic fatty liver disease (NAFLD). Three kinds of probiotic supplements, including lactic acid bacteria (LAB), LAB/LF...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhen-Shu, Li, Pei-Lin, Ku, Yu-We, Chen, Po-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694622/
https://www.ncbi.nlm.nih.gov/pubmed/36363807
http://dx.doi.org/10.3390/microorganisms10112215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694622/
https://www.ncbi.nlm.nih.gov/pubmed/36363807
http://dx.doi.org/10.3390/microorganisms10112215

Ejemplares similares